DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder

A. Chiesa, Chi Un Pae, S. Porcelli, Changsu Han, S. J. Lee, A. A. Patkar, Moon Ho Park, T. Y. Jun, A. Serretti

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: This study investigated whether selected D-amino acid oxidase activator (DAOA) gene single nucleotide polymorphisms (SNPs; rs3916966, rs3916967, rs2391191, rs3916968, rs7139958, rs9558571, rs778293) are associated with major depressive disorder (MDD) and bipolar disorder (BD), and whether they can predict clinical outcomes in Korean in-patients treated with antidepressants and mood stabilizers, respectively. Methods: In total, 145 patients with MDD, 132 patients with BD and 170 psychiatrically healthy controls were genotyped for the DAOA SNPs. Baseline and final clinical assessments included the Montgomery- Asberg Depression Rating Scale and Young Mania Rating Scale for patients with MDD and BD, respectively. Results: There was no association between DAOA SNP genotypes or alleles with diagnosis, clinical improvement, response rates or remission rates for MDD and BD. Haplotype analyses found no association with MDD or BD diagnosis or clinical outcomes. Conclusion: The findings suggest that the DAOA SNPs investigated may not affect MDD or BD phenotype, clinical symptoms or other clinical factors, and are unlikely to be involved in MDD or BD development and treatment outcomes. Given the study's limitations, further investigation should be carried out.

Original languageEnglish
Pages (from-to)258-265
Number of pages8
JournalJournal of International Medical Research
Volume40
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

D-Amino-Acid Oxidase
Major Depressive Disorder
Bipolar Disorder
Single Nucleotide Polymorphism
Therapeutics
Polymorphism
Antidepressive Agents
Nucleotides
Genes
Haplotypes
Alleles
Genotype
Depression
Phenotype

Keywords

  • Bipolar disorder
  • Clinical improvement
  • D-amino acid oxidase activator (DAOA)
  • Major depressive disorder
  • Treatment response

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biochemistry, medical

Cite this

DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder. / Chiesa, A.; Pae, Chi Un; Porcelli, S.; Han, Changsu; Lee, S. J.; Patkar, A. A.; Park, Moon Ho; Jun, T. Y.; Serretti, A.

In: Journal of International Medical Research, Vol. 40, No. 1, 01.01.2012, p. 258-265.

Research output: Contribution to journalArticle

Chiesa, A. ; Pae, Chi Un ; Porcelli, S. ; Han, Changsu ; Lee, S. J. ; Patkar, A. A. ; Park, Moon Ho ; Jun, T. Y. ; Serretti, A. / DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder. In: Journal of International Medical Research. 2012 ; Vol. 40, No. 1. pp. 258-265.
@article{33039775aca14b9f828070a1ed3132ba,
title = "DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder",
abstract = "Objective: This study investigated whether selected D-amino acid oxidase activator (DAOA) gene single nucleotide polymorphisms (SNPs; rs3916966, rs3916967, rs2391191, rs3916968, rs7139958, rs9558571, rs778293) are associated with major depressive disorder (MDD) and bipolar disorder (BD), and whether they can predict clinical outcomes in Korean in-patients treated with antidepressants and mood stabilizers, respectively. Methods: In total, 145 patients with MDD, 132 patients with BD and 170 psychiatrically healthy controls were genotyped for the DAOA SNPs. Baseline and final clinical assessments included the Montgomery- Asberg Depression Rating Scale and Young Mania Rating Scale for patients with MDD and BD, respectively. Results: There was no association between DAOA SNP genotypes or alleles with diagnosis, clinical improvement, response rates or remission rates for MDD and BD. Haplotype analyses found no association with MDD or BD diagnosis or clinical outcomes. Conclusion: The findings suggest that the DAOA SNPs investigated may not affect MDD or BD phenotype, clinical symptoms or other clinical factors, and are unlikely to be involved in MDD or BD development and treatment outcomes. Given the study's limitations, further investigation should be carried out.",
keywords = "Bipolar disorder, Clinical improvement, D-amino acid oxidase activator (DAOA), Major depressive disorder, Treatment response",
author = "A. Chiesa and Pae, {Chi Un} and S. Porcelli and Changsu Han and Lee, {S. J.} and Patkar, {A. A.} and Park, {Moon Ho} and Jun, {T. Y.} and A. Serretti",
year = "2012",
month = "1",
day = "1",
doi = "10.1177/147323001204000126",
language = "English",
volume = "40",
pages = "258--265",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "1",

}

TY - JOUR

T1 - DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder

AU - Chiesa, A.

AU - Pae, Chi Un

AU - Porcelli, S.

AU - Han, Changsu

AU - Lee, S. J.

AU - Patkar, A. A.

AU - Park, Moon Ho

AU - Jun, T. Y.

AU - Serretti, A.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective: This study investigated whether selected D-amino acid oxidase activator (DAOA) gene single nucleotide polymorphisms (SNPs; rs3916966, rs3916967, rs2391191, rs3916968, rs7139958, rs9558571, rs778293) are associated with major depressive disorder (MDD) and bipolar disorder (BD), and whether they can predict clinical outcomes in Korean in-patients treated with antidepressants and mood stabilizers, respectively. Methods: In total, 145 patients with MDD, 132 patients with BD and 170 psychiatrically healthy controls were genotyped for the DAOA SNPs. Baseline and final clinical assessments included the Montgomery- Asberg Depression Rating Scale and Young Mania Rating Scale for patients with MDD and BD, respectively. Results: There was no association between DAOA SNP genotypes or alleles with diagnosis, clinical improvement, response rates or remission rates for MDD and BD. Haplotype analyses found no association with MDD or BD diagnosis or clinical outcomes. Conclusion: The findings suggest that the DAOA SNPs investigated may not affect MDD or BD phenotype, clinical symptoms or other clinical factors, and are unlikely to be involved in MDD or BD development and treatment outcomes. Given the study's limitations, further investigation should be carried out.

AB - Objective: This study investigated whether selected D-amino acid oxidase activator (DAOA) gene single nucleotide polymorphisms (SNPs; rs3916966, rs3916967, rs2391191, rs3916968, rs7139958, rs9558571, rs778293) are associated with major depressive disorder (MDD) and bipolar disorder (BD), and whether they can predict clinical outcomes in Korean in-patients treated with antidepressants and mood stabilizers, respectively. Methods: In total, 145 patients with MDD, 132 patients with BD and 170 psychiatrically healthy controls were genotyped for the DAOA SNPs. Baseline and final clinical assessments included the Montgomery- Asberg Depression Rating Scale and Young Mania Rating Scale for patients with MDD and BD, respectively. Results: There was no association between DAOA SNP genotypes or alleles with diagnosis, clinical improvement, response rates or remission rates for MDD and BD. Haplotype analyses found no association with MDD or BD diagnosis or clinical outcomes. Conclusion: The findings suggest that the DAOA SNPs investigated may not affect MDD or BD phenotype, clinical symptoms or other clinical factors, and are unlikely to be involved in MDD or BD development and treatment outcomes. Given the study's limitations, further investigation should be carried out.

KW - Bipolar disorder

KW - Clinical improvement

KW - D-amino acid oxidase activator (DAOA)

KW - Major depressive disorder

KW - Treatment response

UR - http://www.scopus.com/inward/record.url?scp=84863290878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863290878&partnerID=8YFLogxK

U2 - 10.1177/147323001204000126

DO - 10.1177/147323001204000126

M3 - Article

C2 - 22429365

AN - SCOPUS:84863290878

VL - 40

SP - 258

EP - 265

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 1

ER -